176 related articles for article (PubMed ID: 23680223)
21. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
[TBL] [Abstract][Full Text] [Related]
22. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.
Jørgensen KJ; Gøtzsche PC
BMJ; 2009 Jul; 339():b2587. PubMed ID: 19589821
[TBL] [Abstract][Full Text] [Related]
23. Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.
Prescrire Int; 2015 Jul; 24(162):186-9, 191. PubMed ID: 26240891
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation.
Arrospide A; Rue M; van Ravesteyn NT; Comas M; Larrañaga N; Sarriugarte G; Mar J
BMC Cancer; 2015 Oct; 15():671. PubMed ID: 26459293
[TBL] [Abstract][Full Text] [Related]
25. The Screening Illustrator: separating the effects of lead-time and overdiagnosis in mammography screening.
Lousdal ML; Møller MH; Kristiansen IS; Kalager M; Wisløff T; Støvring H
Eur J Public Health; 2018 Dec; 28(6):1138-1142. PubMed ID: 29796623
[TBL] [Abstract][Full Text] [Related]
26. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
Harding C; Pompei F; Burmistrov D; Wilson R
Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
[TBL] [Abstract][Full Text] [Related]
27. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.
Etzioni R; Gulati R; Mallinger L; Mandelblatt J
Ann Intern Med; 2013 Jun; 158(11):831-8. PubMed ID: 23732716
[TBL] [Abstract][Full Text] [Related]
28. Overdiagnosis among women attending a population-based mammography screening program.
Falk RS; Hofvind S; Skaane P; Haldorsen T
Int J Cancer; 2013 Aug; 133(3):705-12. PubMed ID: 23355313
[TBL] [Abstract][Full Text] [Related]
29. Interpreting overdiagnosis estimates in population-based mammography screening.
de Gelder R; Heijnsdijk EA; van Ravesteyn NT; Fracheboud J; Draisma G; de Koning HJ
Epidemiol Rev; 2011; 33(1):111-21. PubMed ID: 21709144
[TBL] [Abstract][Full Text] [Related]
30. Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.
Gunsoy NB; Garcia-Closas M; Moss SM
Breast Cancer Res; 2012 Nov; 14(6):R152. PubMed ID: 23194032
[TBL] [Abstract][Full Text] [Related]
31. Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort.
Ryser MD; Lange J; Inoue LYT; O'Meara ES; Gard C; Miglioretti DL; Bulliard JL; Brouwer AF; Hwang ES; Etzioni RB
Ann Intern Med; 2022 Apr; 175(4):471-478. PubMed ID: 35226520
[TBL] [Abstract][Full Text] [Related]
32. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.
Ripping TM; Verbeek AL; Ten Haaf K; van Ravesteyn NT; Broeders MJ
Cancer Epidemiol; 2016 Jun; 42():147-53. PubMed ID: 27153471
[TBL] [Abstract][Full Text] [Related]
33. The benefits and harms of breast cancer screening: an independent review.
Independent UK Panel on Breast Cancer Screening
Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
[TBL] [Abstract][Full Text] [Related]
34. Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods.
Seigneurin A; Labarère J; Duffy SW; Colonna M
Cancer Epidemiol; 2015 Dec; 39(6):1128-35. PubMed ID: 26341587
[TBL] [Abstract][Full Text] [Related]
35. Overdiagnosis of invasive breast cancer in population-based breast cancer screening: A short- and long-term perspective.
Ding L; Poelhekken K; Greuter MJW; Truyen I; De Schutter H; Goossens M; Houssami N; Van Hal G; de Bock GH
Eur J Cancer; 2022 Sep; 173():1-9. PubMed ID: 35839596
[TBL] [Abstract][Full Text] [Related]
36. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
Johns LE; Coleman DA; Swerdlow AJ; Moss SM
Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
[TBL] [Abstract][Full Text] [Related]
37. Overdiagnosis in Mammographic Screening because of Competing Risk of Death.
Falk RS; Hofvind S
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):759-65. PubMed ID: 26976857
[TBL] [Abstract][Full Text] [Related]
38. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
[TBL] [Abstract][Full Text] [Related]
39. [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].
Gocko X; Leclerq M; Plotton C
Rev Epidemiol Sante Publique; 2018 Nov; 66(6):395-403. PubMed ID: 30316554
[TBL] [Abstract][Full Text] [Related]
40. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
